Product Information

ARISTADA ER 441 MG/1.6 ML SYRN is a brand product labeled by Alkermes, Inc., priced at $1004.2964 per ML under NDC 65757040103. Its NADAC has been published 492 times since Mar 22, 2017.

FDA first approved this application on Oct 5, 2015.

ARISTADA ER 441 MG/1.6 ML SYRN

aripiprazole lauroxil
$1004.2964per ML

Strength

441 mg/1.6mL

Manufacturer

Alkermes, Inc.

NDC

65757040103

Classification

Brand

Dosage Form

INJECTION, SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Effective Date

8/19/2026

Active Ingredients

ARIPIPRAZOLE LAUROXIL

Approval Type

New Drug (NDA)

FDA Application

NDA207533

FDA Approved

10/5/2015

On Market Since

10/5/2015

Pharmacological Classes

Price Statistics

The NADAC for ARISTADA ER 441 MG/1.6 ML SYRN has been published 492 times since Mar 22, 2017, and over the history we have for it it has risen 55.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1004.2964 per ML
All-time high$1004.2964 (Aug 19, 2026)
All-time low$647.8787 (Mar 22, 2017)
52-week high$1004.2964
52-week low$941.5190
Median price$849.2968
Average price$839.1646
Largest weekly change+6.0% (Apr 15, 2020)
Weeks tracked492
Tracking sinceMar 22, 2017

Price History

1W

+1.1%

1M

+1.1%

3M

+2.0%

6M

+0.5%

1Y

+6.7%

3Y

+11.9%

5Y

+18.3%

All

+55.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the aripiprazole lauroxil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ARISTADA ER 441 MG/1.6 ML SYRN?

The current National Average Drug Acquisition Cost (NADAC) for ARISTADA ER 441 MG/1.6 ML SYRN, manufactured by Alkermes, Inc., is $1004.2964 per ML (NDC 65757040103), effective Aug 19, 2026.

How has the price of ARISTADA ER 441 MG/1.6 ML SYRN changed over time?

Over the history we have for it, the NADAC for ARISTADA ER 441 MG/1.6 ML SYRN has risen 55.0%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.

What are the highest and lowest recorded NADAC prices for ARISTADA ER 441 MG/1.6 ML SYRN?

Since Mar 22, 2017, the NADAC for ARISTADA ER 441 MG/1.6 ML SYRN has ranged from a low of $647.8787 (Mar 22, 2017) to a high of $1004.2964 (Aug 19, 2026), with a median of $849.2968 per ML.

Are there cheaper alternatives to ARISTADA ER 441 MG/1.6 ML SYRN?

No other NADAC-published product currently shares the active ingredient and strength of ARISTADA ER 441 MG/1.6 ML SYRN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ARISTADA ER 441 MG/1.6 ML SYRN?

ARISTADA ER 441 MG/1.6 ML SYRN (NDC 65757040103) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.